These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7976264)

  • 1. Experimental perforating injury with high energy electrons to inhibit intraocular proliferation.
    Velikay M; Binder S; Stolba U; Wedrich A; Datlinger P; Handl-Zeller L
    Acta Ophthalmol (Copenh); 1994 Jun; 72(3):337-40. PubMed ID: 7976264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiproliferative effect of fractionized radiation therapy: optimization of dosage.
    Velikay M; Stolba U; Wedrich A; Datlinger P; Akramian J; Binder S
    Doc Ophthalmol; 1994; 87(3):265-9. PubMed ID: 7835195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy.
    Ozerdem U; Mach-Hofacre B; Keefe K; Pham T; Soules K; Appelt K; Freeman WR
    Ophthalmic Res; 2001; 33(1):20-3. PubMed ID: 11114600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental posterior perforating ocular injury in rabbit eyes: effects of radiotherapy with or without intravitreal cyclosporin on vitreous proliferation.
    Karakücük S; Soyuer S; Oner AO; Soyuer I; Yaray K; Mirza E; Baskol G; Akin A
    Ophthalmologica; 2006; 220(1):6-11. PubMed ID: 16374042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-energy electrons used to inhibit experimental intraocular proliferation and detachment.
    Binder S; Skorpik C; Paroussis P; Kulnig W; Menapace R; Prokesch E
    Ophthalmologica; 1987; 195(3):128-34. PubMed ID: 3696702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.
    Kuriyama S; Ohuchi T; Yoshimura N; Honda Y; Hiraoka M; Abe M
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):552-5. PubMed ID: 2265771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of leukopenia on experimental post-traumatic retinal detachment.
    Gabrielian K; Wang HM; Lee M; Ogden TE; Ryan SJ
    Curr Eye Res; 1994 Jan; 13(1):1-9. PubMed ID: 8156820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.
    Khanum BNMK; Guha R; Sur VP; Nandi S; Basak SK; Konar A; Hazra S
    Eye (Lond); 2017 Sep; 31(9):1317-1328. PubMed ID: 28304388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitreoretinal proliferation as a cause of tractional retinal ablation after severe perforating injury].
    Vicić D; Smiljanić N; Golijanin-Zaklan T; Aleksić P; Tanjga S
    Vojnosanit Pregl; 1995; 52(1):12-7. PubMed ID: 7638944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a pilot study.
    Abdullatif AM; Macky TA; Abdullatif MM; Nassar K; Grisanti S; Mortada HA; Soliman MM
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2473-2481. PubMed ID: 30128605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intravitreal bevacizumab in experimental posterior penetrating eye injury.
    Mehdizadeh M; Fattahi F; Eghtedari M; Nowroozzadeh MH; Toosi F
    Retina; 2011 Jan; 31(1):154-60. PubMed ID: 20838359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior perforating eye injury. Experimental animal model.
    Cleary PE; Ryan SJ
    Trans Ophthalmol Soc U K (1962); 1978 Apr; 98(1):34-7. PubMed ID: 107626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of scleral buckle in experimental posterior penetrating eye injury.
    Men G; Peyman GA; Kuo PC; Bezerra Y; Ghahramani F; Naaman G; Livir-Rallatos C; Lee PJ
    Retina; 2003 Apr; 23(2):202-8. PubMed ID: 12707600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforating ocular injury by Taser.
    Chen SL; Richard CK; Murthy RC; Lauer AK
    Clin Exp Ophthalmol; 2006; 34(4):378-80. PubMed ID: 16764662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAUMATIC PROLIFERATIVE VITREORETINOPATHY: Clinical and Histopathological Observations.
    Jin Y; Chen H; Xu X; Hu Y; Wang C; Ma Z
    Retina; 2017 Jul; 37(7):1236-1245. PubMed ID: 27779559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
    Yu HG; Chung H
    Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic chorioretinectomy for eye injuries with high proliferative-vitreoretinopathy risk.
    Kuhn F; Schrader W
    Clin Anat; 2018 Jan; 31(1):28-38. PubMed ID: 28635048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraocular fibrosis after perforating injury of the posterior segment. Experimental study].
    Kantelip B; Bacin F
    J Fr Ophtalmol; 1985; 8(3):245-53. PubMed ID: 4056316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy.
    Fastenberg DM; Diddie KR; Delmage JM; Dorey K
    Am J Ophthalmol; 1983 May; 95(5):663-7. PubMed ID: 6846457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.